Substance | Condition | Seq | Src | PMID | Dtl | Title |
Ginseng | Cystic Fibrosis | 1 | PM | 37704464 | 📋 | Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways |
Ginseng | Hepatic Fibrosis | 4 | PM | 35265144 | 📋 | Exploring the Mechanism of Astragalus propinquus Schischkin and Panax Notoginseng (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis |
Ginseng | Hepatic Fibrosis | 3 | PM | 34634746 | 📋 | A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl 4-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade |
Ginseng | Hepatic Fibrosis | 2 | PM | 33292321 | 📋 | Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease |
Ginseng | Hepatic Fibrosis | 1 | PM | 31695567 | 📋 | Hepatoprotective Effect of Ultrasonicated Ginseng Berry Extract on a Rat Mild Bile Duct Ligation Model |
Ginseng | Hepatic Fibrosis | 5 | PM | 29593815 | 📋 | Preventive effects of total saponins of Panax japonicus on fatty liver fibrosis in mice |
Ginseng | Kidney Fibrosis | 5 | PM | 38809875 | 📋 | Combined use of Panax notoginseng and leech provides new insights into renal fibrosis: Restoration of mitochondrial kinetic imbalance |
Ginseng | Kidney Fibrosis | 4 | PM | 37073148 | 📋 | Panax Notoginseng Saponins Alleviate LPS-induced Fibrosis of HK-2 Cells by Inhibiting the Activation of NLRP3 Inflammasome and Pyroptosis |
Ginseng | Kidney Fibrosis | 3 | PM | 34823789 | 📋 | Novel pectin-like polysaccharide from Panax notoginseng attenuates renal tubular cells fibrogenesis induced by TGF-β |
Ginseng | Kidney Fibrosis | 2 | PM | 34025134 | 📋 | Saponins from Panax japonicus ameliorate age-related renal fibrosis by inhibition of inflammation mediated by NF-κB and TGF-β1/Smad signaling and suppression of oxidative stress via activation of Nrf2-ARE signaling |
Ginseng | Kidney Fibrosis | 1 | PM | 33292321 | 📋 | Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease |
Ginseng | Myocardial Fibrosis | 3 | PM | 35401934 | 📋 | Traditional Chinese Medicine Ginseng Dingzhi Decoction Ameliorates Myocardial Fibrosis and High Glucose-Induced Cardiomyocyte Injury by Regulating Intestinal Flora and Mitochondrial Dysfunction |
Ginseng | Myocardial Fibrosis | 2 | PM | 35372585 | 📋 | Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
Ginseng | Myocardial Fibrosis | 1 | PM | 33292321 | 📋 | Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease |
Ginseng | Oral Submucous Fibrosis | 1 | PM | 38632037 | 📋 | Panax notoginseng saponins improve oral submucous fibrosis by inhabiting the Wnt/β-catenin signal pathway |
Ginseng | Pulmonary Fibrosis | 7 | PM | 38584671 | 📋 | Ferroptosis Mediates Pulmonary Fibrosis: Implications for the Effect of Astragalus and Panax notoginseng Decoction |
Ginseng | Pulmonary Fibrosis | 6 | PM | 38276557 | 📋 | Anti-Fibrosis Effect of Panax ginseng and Inula japonica Formula in Human Pulmonary Fibroblasts |
Ginseng | Pulmonary Fibrosis | 5 | PM | 37532070 | 📋 | Panax notoginseng saponin alleviates pulmonary fibrosis in rats by modulating the renin-angiotensin system |
Ginseng | Pulmonary Fibrosis | 4 | PM | 37397411 | 📋 | Ginseng saponin metabolite 20(S)-protopanaxadiol relieves pulmonary fibrosis by multiple-targets signaling pathways |
Ginseng | Pulmonary Fibrosis | 3 | PM | 35865337 | 📋 | Panax Notoginseng Saponins Regulate Transforming Growth Factor- β 1 through MAPK and Snail/TWIST1 Signaling Pathway to Inhibit Epithelial-Mesenchymal Transition of Pulmonary Fibrosis in A549 Cells |
Ginseng | Pulmonary Fibrosis | 2 | PM | 33307846 | 📋 | Preparation, optimization, and in vivo evaluation of an inhaled solution of total saponins of Panax notoginseng and its protective effect against idiopathic pulmonary fibrosis |
Ginseng | Pulmonary Fibrosis | 1 | PM | 33292321 | 📋 | Panax ginseng C. A. Meyer as a potential therapeutic agent for organ fibrosis disease |